Department of Infectious Diseases, University of Tsukuba Hospital, Japan.
Department of Rheumatology, University of Tsukuba Hospital, Japan.
J Infect Chemother. 2021 Aug;27(8):1238-1243. doi: 10.1016/j.jiac.2021.02.023. Epub 2021 Mar 13.
Although a variety of microorganisms have caused infective endocarditis, Nocardia species have rarely been reported as a causative agent of the disease. We describe a case of nocardial endocarditis, occurring to a 22-year-old Japanese woman during long-term corticosteroid therapy for adult-onset Still's disease and diagnosed after the rupture of cerebral mycotic aneurysm. Echocardiography showed that the causative organism, isolated from the blood and identified as Nocardia nova with an analysis of 16S ribosomal RNA sequences, affected the posterior papillary muscle of the left ventricle. Nocardia-like organisms were also detected in the pus around the raptured aneurysm. After treatment with imipenem/cilastatin plus amikacin for 3 months followed by oral trimethoprim/sulfamethoxazole for 1 year, no relapse of nocardiosis occurred during a follow-up for 3 years. To our knowledge, the present case is the first reported endocarditis due to N. nova.
虽然有多种微生物可引起感染性心内膜炎,但诺卡氏菌属很少被报道为该病的致病因子。我们描述了一例诺卡氏菌心内膜炎病例,发生于一名 22 岁的日本女性,该女性因成人Still 病接受长期皮质类固醇治疗,并发脑真菌性动脉瘤破裂后确诊。超声心动图显示,从血液中分离出的并经 16S 核糖体 RNA 序列分析鉴定为新诺卡氏菌的病原体影响了左心室后乳头肌。在破裂的动脉瘤周围的脓液中也检测到了类似诺卡氏菌的生物体。在接受亚胺培南/西司他丁联合阿米卡星治疗 3 个月,随后口服复方磺胺甲噁唑治疗 1 年后,在 3 年的随访期间,诺卡氏菌病未再复发。据我们所知,本例是首例报道的由新诺卡氏菌引起的心内膜炎。